Skip to content

Laser treatment of facial hirsutism in women with polycystic ovary syndrome (PCOS)

Laser treatment of facial hirsutism in women with polycystic ovary syndrome (PCOS): assessing its effect on quality of life

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12618001704280
Enrollment
28
Registered
2018-10-16
Start date
2018-11-02
Completion date
2019-08-30
Last updated
2018-11-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Polycystic ovary syndrome (PCOS) is a common condition which affects up to 18% of young women. It is caused by hormonal disturbances and is associated with significant reproductive, metabolic, and psychological complications. Hirsutism is defined as excessive hair growth in a woman. It is often a key concern for women with PCOS, but is often overlooked by health professionals. Conversely, it is of high importance as it has a deleterious effect on self-esteem, emotional wellbeing and quality of life, especially in women with PCOS. Laser hair removal therapy, is widely used and thought to be effective in reducing severity of hirsutism and improve quality of life but its use in women with PCOS is less well-studied. We intend to conduct a before and after trial to observe the efficacy of laser therapy in treating facial hirsutism in women with PCOS. We will assess changes in hirsutism severity and also its impact on psychological outcomes in women with PCOS.

Interventions

Women with polycystic ovary syndrome and facial hirsutism will be treated by the Cutera excel HR laser for hair reduction. The treatment dose will be set according to the participant skin type. Participant will be followed-up for 8 treatments, each 4-6 weekly apart. The estimated follow-up period is estimated to be 9 to 12 months depending on the participant's treatment schedule.

Sponsors

Monash Centre for Health Research and Implementation
Lead SponsorUniversity

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

• Women with polycystic ovary syndrome • Patient with troublesome facial hirsutism • Patient who never had laser hair reduction to the face

Exclusion criteria

• Women without PCOS • Non-facial hirsutism only • Contraindication to laser photoepilation (e.g. previous adverse events, skin cancer, pregnancy) • Presence of other skin conditions at the intended treatment area • Patient who had previous laser hair reduction treatment to the face • Patient who last had laser hair reduction to the body =24 months ago

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026